| Target Price | €612.00 |
| Price | €362.00 |
| Potential |
69.06%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Limes Schlosskliniken 2027 .
The average Limes Schlosskliniken target price is €612.00.
This is
69.06%
register free of charge
€630.00
74.03%
register free of charge
€606.00
67.40%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Limes Schlosskliniken to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Limes Schlosskliniken stock has an average upside potential 2027 of
69.06%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 38.12 | 50.00 |
| 0.42% | 31.15% | |
| EBITDA Margin | 18.49% | 22.83% |
| 8.47% | 23.44% | |
| Net Margin | 8.16% | 11.28% |
| 8.91% | 38.26% |
2 Analysts have issued a sales forecast Limes Schlosskliniken 2025 . The average Limes Schlosskliniken sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Limes Schlosskliniken EBITDA forecast 2025. The average Limes Schlosskliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Limes Schlosskliniken Analysts have issued a net profit forecast 2025. The average Limes Schlosskliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 10.61 | 19.45 |
| 8.38% | 83.32% | |
| P/E | 18.61 | |
| EV/Sales | 2.15 |
2 Analysts have issued a Limes Schlosskliniken forecast for earnings per share. The average Limes Schlosskliniken EPS is
This results in the following potential growth metrics and future valuations:
Limes Schlosskliniken...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


